KUKJEON PHARMACEUTICAL Statistics

Total Valuation

KOSDAQ:307750 has a market cap or net worth of KRW 157.64 billion. The enterprise value is 176.21 billion.

Market Cap	157.64B
Enterprise Value	176.21B

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

KOSDAQ:307750 has 49.97 million shares outstanding.

Current Share Class	49.97M
Shares Outstanding	49.97M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	60.88%
Owned by Institutions (%)	0.09%
Float	19.54M

Valuation Ratios

The trailing PE ratio is 89.17.

PE Ratio	89.17
Forward PE	n/a
PS Ratio	1.16
PB Ratio	1.62
P/TBV Ratio	1.64
P/FCF Ratio	72.68
P/OCF Ratio	15.71
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.55, with an EV/FCF ratio of 81.24.

EV / Earnings	101.49
EV / Sales	1.29
EV / EBITDA	32.55
EV / EBIT	n/a
EV / FCF	81.24

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.67.

Current Ratio	1.19
Quick Ratio	0.85
Debt / Equity	0.67
Debt / EBITDA	11.94
Debt / FCF	30.11
Interest Coverage	0.04

Financial Efficiency

Return on equity (ROE) is 0.55% and return on invested capital (ROIC) is 0.14%.

Return on Equity (ROE)	0.55%
Return on Assets (ROA)	0.10%
Return on Invested Capital (ROIC)	0.14%
Return on Capital Employed (ROCE)	0.30%
Revenue Per Employee	788.83M
Profits Per Employee	10.04M
Employee Count	173
Asset Turnover	0.62
Inventory Turnover	4.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.25% in the last 52 weeks. The beta is -1.00, so KOSDAQ:307750's price volatility has been lower than the market average.

Beta (5Y)	-1.00
52-Week Price Change	-43.25%
50-Day Moving Average	3,195.80
200-Day Moving Average	3,910.85
Relative Strength Index (RSI)	47.54
Average Volume (20 Days)	23,225

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:307750 had revenue of KRW 136.47 billion and earned 1.74 billion in profits. Earnings per share was 35.38.

Revenue	136.47B
Gross Profit	21.87B
Operating Income	366.71M
Pretax Income	879.32M
Net Income	1.74B
EBITDA	5.47B
EBIT	366.71M
Earnings Per Share (EPS)	35.38

Full Income Statement

Balance Sheet

The company has 46.82 billion in cash and 65.31 billion in debt, giving a net cash position of -18.49 billion or -370.01 per share.

Cash & Cash Equivalents	46.82B
Total Debt	65.31B
Net Cash	-18.49B
Net Cash Per Share	-370.01
Equity (Book Value)	97.50B
Book Value Per Share	1,985.36
Working Capital	16.61B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.04 billion and capital expenditures -7.87 billion, giving a free cash flow of 2.17 billion.

Operating Cash Flow	10.04B
Capital Expenditures	-7.87B
Free Cash Flow	2.17B
FCF Per Share	43.41

Full Cash Flow Statement

Margins

Gross margin is 16.03%, with operating and profit margins of 0.27% and 1.27%.

Gross Margin	16.03%
Operating Margin	0.27%
Pretax Margin	0.64%
Profit Margin	1.27%
EBITDA Margin	4.01%
EBIT Margin	0.27%
FCF Margin	1.59%

Dividends & Yields

This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 0.32%.

Dividend Per Share	10.00
Dividend Yield	0.32%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	28.26%
Buyback Yield	n/a
Shareholder Yield	0.32%
Earnings Yield	1.10%
FCF Yield	1.38%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:307750 has an Altman Z-Score of 2.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.25
Piotroski F-Score	n/a